Literature DB >> 8760299

Neovascularization in human germ cell tumors correlates with a marked increase in the expression of the vascular endothelial growth factor but not the placenta-derived growth factor.

G Viglietto1, A Romano, D Maglione, M Rambaldi, I Paoletti, C T Lago, D Califano, C Monaco, A Mineo, G Santelli, G Manzo, G Botti, G Chiappetta, M G Persico.   

Abstract

Neoangiogenesis is a prerequisite for tumor growth and metastasis. In germ cell cancer patients with the disease limited to the testicle (stage A), tumor-associated neovascularization is predictive of metastatic disease (stage B). To investigate the molecular mechanisms underlying neovascularization in human germ cell tumors (GCTs), we analysed the expression of two angiogenic growth factors, vascular endothelial growth factor (VEGF) and placenta growth factor (P1GF), and of their receptors (FLT-1) and Flk-1/KDR) in a panel of testicular tumors. In this study we show a marked increase in VEGF expression in 36/44 (81.8%) primary testicular-derived GCTs, as compared to normal testis, that significantly correlates with a high density of intratumor microvessels (r = 0.72461, P < 0.001; n = 24). As determined by RT - PCR and/or Western blot, the predominant VEGF isoforms expressed in GCTs are the VEGF121 and VEGF165, which are more efficiently secreted by the cells, and thus more active in eliciting angiogenesis. Conversely, in the case of PIGF, only a weak correlation with the vascular density of tumors is observed (r = 0.26599, P < 0.05; n = 24). Northern blot analysis also revealed significant up-regulation of VEGF/ PIGF receptors in highly vascularized germ cell tumors, compared to normal testes. These findings suggest that VEGF may act in a paracrine manner to induce neovascularization, oedema extravasation and cyst formation in human germ cell tumors. The correlation between VEGF expression and the vascular density of tumors, suggest that the evaluation of VEGF expression may be of help in predicting patients at risk for metastatic diseases. Finally, we demonstrate that VEGF up-regulation may occur at the RNA level since no gene amplification is observed; conversely, in in vitro models such as the embryonal stem cell line NTERA-2 and the choricarcinoma JEG-3 cell line, VEGF (but not PIGF) mRNA expression is regulated by hypoxic stress.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8760299

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  17 in total

Review 1.  Microinvasive germ cell tumor of the testis.

Authors:  Finn Edler von Eyben; Grete Krag Jacobsen; Rolf Inge Skotheim
Journal:  Virchows Arch       Date:  2005-06-21       Impact factor: 4.064

2.  Retinoblastoma: value of dynamic contrast-enhanced MR imaging and correlation with tumor angiogenesis.

Authors:  F Rodjan; P de Graaf; P van der Valk; A C Moll; J P A Kuijer; D L Knol; J A Castelijns; P J W Pouwels
Journal:  AJNR Am J Neuroradiol       Date:  2012-05-24       Impact factor: 3.825

3.  EGFL7 is a chemoattractant for endothelial cells and is up-regulated in angiogenesis and arterial injury.

Authors:  Luisa Campagnolo; Amy Leahy; Smita Chitnis; Stefan Koschnick; Michael J Fitch; John T Fallon; David Loskutoff; Mark B Taubman; Heidi Stuhlmann
Journal:  Am J Pathol       Date:  2005-07       Impact factor: 4.307

4.  Novel compounds with antiangiogenic and antiproliferative potency for growth control of testicular germ cell tumours.

Authors:  B Nitzsche; C Gloesenkamp; M Schrader; M Ocker; R Preissner; M Lein; A Zakrzewicz; B Hoffmann; M Höpfner
Journal:  Br J Cancer       Date:  2010-06-15       Impact factor: 7.640

5.  Final Report of the First Refractory Germ Cell Tumor Treated with Sunitinib Malate.

Authors:  Joan Manel Gasent Blesa; Enrique Grande Pulido; Juan Laforga Canales; Vicente Alberola Candel
Journal:  Case Rep Oncol       Date:  2009-12-11

Review 6.  Emerging Therapeutic Targets for Male Germ Cell Tumors.

Authors:  Christian Daniel Fankhauser; Friedemann Honecker; Jörg Beyer; Peter Karl Bode
Journal:  Curr Oncol Rep       Date:  2015-12       Impact factor: 5.075

7.  Phase II trial of sunitinib in patients with relapsed or refractory germ cell tumors.

Authors:  Darren R Feldman; Stefan Turkula; Michelle S Ginsberg; Nicole Ishill; Sujata Patil; Maryann Carousso; George J Bosl; Robert J Motzer
Journal:  Invest New Drugs       Date:  2009-06-23       Impact factor: 3.850

Review 8.  Chemotherapy for patients with poor prognosis germ cell tumors.

Authors:  Matthew J Riese; David J Vaughn
Journal:  World J Urol       Date:  2009-03-28       Impact factor: 4.226

Review 9.  [Urine-based markers of angiogenesis in bladder cancer].

Authors:  M Becker; D Tilki; T Szarvas; H Rübben; S Ergün
Journal:  Urologe A       Date:  2009-06       Impact factor: 0.639

10.  Serum human chorionic gonadotropin is associated with angiogenesis in germ cell testicular tumors.

Authors:  Oscar Arrieta; Rosa Mayela Michel Ortega; Julián Angeles-Sánchez; Cynthia Villarreal-Garza; Alejandro Avilés-Salas; José G Chanona-Vilchis; Elena Aréchaga-Ocampo; Arturo Luévano-González; Miguel Angel Jiménez; José Luis Aguilar
Journal:  J Exp Clin Cancer Res       Date:  2009-08-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.